bile salt kinetics cystic fibrosis influence pancreatic enzyme replacement bile acid kinetics investigated stable isotope dilution technique 6 child age 3 12 month 4 12 year previously untreated cystic fibrosis patient clinical laboratory evidence malabsorption normal intestinal mucosal function judged glucose absorption intestinal histology disaccharidase level normally functioning gallbladder child maintained constant diet throughout study period fat intake averaged 42 g per kg per day administration pancreatic enzyme replacement fat excretion equalled 50 plus minus 4 mean plus minus se intake reduced 20 plus minus 10 intake therapy total bile acid pool size nearly doubled enzyme replacement 379 plus minus 32 micromoles per kg 620 plus minus 36 micromoles per kg secondary bile acid comprising 57 total pool therapy 40 therapy total bile acid synthesis changed little therapy equalling 139 plus minus 17 micromoles per kg per day total 602 plus minus 109 mg per day without enzyme replacement 125 plus minus 19 micromoles per kg per day total 470 plus minus 86 milligram per day enzyme replacement confirmed fecal excretion bile acid 545 plus minus 166 milligram bile acid per day excreted without enzyme compared 513 plus minus 146 milligram per day enzyme therapy fractional turnover rate bile acid pool reduced 0602 plus minus 005 per day 0233 plus minus 03 per day cholic acidand 0696 plus minus 009 per day 039 plus minus 004 per day chenodeoxycholic acid data indicate primary secondary bile acid conserved within enterohepatic circulation enzyme therapy mechanism regulation hepatic bile acid synthesis intact cystic fibrosis however demonstration large amount bile acid continue excreted therapy suggests interruption enterohepatic circulation continues deficiency intraluminal phase may persist enzyme therapy disease